Greenbrook TMS (GBNH) Stock Price, News & Analysis

Company Overview

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.04 to $0.10
• 50-Day Range: $0.05 to $0.38
• 52-Week Range: $0.10 to $1.82
• Volume: 787,000 shs
• Average Volume: 3.60 million shs
• Market Capitalization: $1.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

GBNH Stock Analysis - Frequently Asked Questions

How were Greenbrook TMS's earnings last quarter?

Greenbrook TMS Inc. (NASDAQ:GBNH) announced its quarterly earnings results on Monday, August, 14th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.01. The company earned $18.35 million during the quarter, compared to analyst estimates of $19.15 million.

Company Calendar

• Last Earnings: 8/14/2023
• Today: 10/06/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GBNH
• CUSIP: N/A
• CIK: 1735948
• Web: www.greenbrooktms.com
• Phone: (416) 928-6076
• Fax: N/A
• Employees: 492
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-61,730,000.00
• Net Margins: -83.19%
• Pretax Margin: -83.55%
• Return on Equity: N/A
• Return on Assets: -66.59%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.47
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $69.10 million
• Price / Sales: 0.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.72) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 40,800,000
• Free Float: 31,959,000
• Market Cap: $1.96 million
• Optionable: Not Optionable
• Beta: 2.19